Compare AVLN & MYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVLN | MYE |
|---|---|---|
| Founded | 2011 | 1933 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2026 | 1995 |
| Metric | AVLN | MYE |
|---|---|---|
| Price | $29.89 | $27.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $61.80 | N/A |
| AVG Volume (30 Days) | ★ 432.2K | 313.5K |
| Earning Date | 11-12-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 1.91% |
| EPS Growth | N/A | ★ 389.47 |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.49 |
| P/E Ratio | ★ N/A | $61.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.24 | $16.66 |
| 52 Week High | $40.17 | $37.45 |
| Indicator | AVLN | MYE |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 38.72 |
| Support Level | $25.86 | $26.72 |
| Resistance Level | $33.32 | $32.10 |
| Average True Range (ATR) | 1.93 | 1.38 |
| MACD | 0.67 | -0.15 |
| Stochastic Oscillator | 74.04 | 19.73 |
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.
Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.